Cargando…

Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study

BACKGROUND: Ayurveda herbal formulation AYUSH-64, proven to treat malaria and influenza-like illness in india was repurposed for COVID-19 patients considering preliminary evidances, however, scientific data was not available. AIM: To evaluate the preliminary efficacy and safety of AYUSH 64 as an add...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakar, Anup, Goyal, Mandip, Bhinde, Sagar, Chhotala, Yagnik, Panara, Kalpesh, Chaudhari, Swapnil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114151/ https://www.ncbi.nlm.nih.gov/pubmed/35600633 http://dx.doi.org/10.1016/j.jaim.2022.100587

Ejemplares similares

Add-on Ayurveda Treatment for Early Stage COVID-19: A Single Center Retrospective Cohort Study From Gujarat, India
por: Thakar, Anup, et al.
Publicado: (2021)

Impact of AYUSH interventions on COVID-19: a protocol for a living systematic review and meta-analysis
por: Thakar, Anup, et al.
Publicado: (2022)

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
por: Singh, Harbans, et al.
Publicado: (2022)

Guduchi Ghanavati (Ayurveda medication) improves the perceived immunity in individuals at risk of SARS-CoV-2: A multicentred, controlled, before-and-after study
por: Thakar, Anup, et al.
Publicado: (2022)

Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
por: Chopra, Arvind, et al.
Publicado: (2023)

AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
por: Reddy, R. Govind, et al.
Publicado: (2020)

Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
por: Rai, Amit Kumar, et al.
Publicado: (2022)

AYUSH- 64: A potential therapeutic agent in COVID-19
por: Panda, Ashok Kumar, et al.
Publicado: (2022)

Influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation
por: Pandey, Deep Narayan, et al.
Publicado: (2020)

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
por: Kasarla, Siva Swapna, et al.
Publicado: (2022)

AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study
por: Gundeti, Manohar S., et al.
Publicado: (2022)

Public perception of AYUSH
por: Patwardhan, Bhushan
Publicado: (2015)

AYUSH and meta-research
por: Tillu, Girish
Publicado: (2019)

Author's reply to correspondence ‘influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation’
por: Gundeti, Manohar S., et al.
Publicado: (2022)

Initiatives: National Ayush Morbidity and Standardized Terminologies Electronic (NAMASTE) Portal
por: Thrigulla, Saketh Ram, et al.
Publicado: (2023)

Role of Virechana and Ashwatha Phala Churna in the management of Ksheena Shukra (oligozoospermia): A pilot study
por: Varsakiya, Jitendra Nathabhai, et al.
Publicado: (2016)

Perspectives in innovation in the AYUSH sector
por: Singh, Ram Harsh
Publicado: (2011)

Integrating AYUSH into Palliative Care
por: Salins, Naveen
Publicado: (2017)

AYUSH for COVID-19 management
por: Tillu, Girish, et al.
Publicado: (2020)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
por: Ram, Thrigulla Saketh, et al.
Publicado: (2022)

Role of Laksha Churna and Madhu Pratisarana after ultrasonic scaling in the management of Dantasharkara (dental calculus): An open-label, standard controlled randomized clinical trial
por: Kathad, Divyarani, et al.
Publicado: (2020)

Universal Health Coverage and AYUSH systems
por: Patwardhan, Bhushan, et al.
Publicado: (2018)

AYUSH for New India: Vision and strategy
por: Shankar, Darshan, et al.
Publicado: (2017)

Efficacy of Virechana (therapeutic purgation) followed by Go-Ghrita (cow ghee) in the management of Ksheena Shukra (oligozoospermia): A clinical study
por: Varsakiya, Jitendra Nathabhai, et al.
Publicado: (2019)

Effect of Opuntia elatior Mill. (Nagaphani) in the management of Pandu Roga w. s. r to iron deficiency anemia; an open labeled randomized standard controlled clinical trial
por: Prajapati, Shashikant M., et al.
Publicado: (2020)

Envisioning AYUSH: Historic Opportunity for Innovation and Revitalization
por: Patwardhan, Bhushan
Publicado: (2014)

AYUSH research for New India: Vision and strategies()
por: Tillu, Girish
Publicado: (2018)

The journey with COVID-19: Initiatives by Ministry of AYUSH
por: Kotecha, Rajesh
Publicado: (2021)

A compendious review of Chitraka Haritaki Avaleha – A polyherbal Ayurveda formulation for bronchial asthma
por: Bhinde, Sagar Mahendrabhai, et al.
Publicado: (2020)

Lavender (Lavandula angustifolia) syrup as an adjunct to standard care in patients with mild to moderate COVID-19: An open-label, randomized, controlled clinical trial
por: Qaraaty, Marzieh, et al.
Publicado: (2023)

A case study on the Ayurvedic management of cerebral palsy
por: Bhinde, Sagar Mahendrabhai
Publicado: (2015)

Consequences of excessive use of Amlarasa (sour taste): A case-control study
por: Panara, Kalpesh B., et al.
Publicado: (2014)

Practices at an AYUSH health camp for asthma in Pendra, Chhattisgarh
por: Madhu, Raghavendra
Publicado: (2011)

Is ‘mainstreaming AYUSH’ the right policy for Meghalaya, northeast India?
por: Albert, Sandra, et al.
Publicado: (2015)

Central nervous system depressant activity of Jatamansi (Nardostachys jatamansi DC.) rhizome
por: Panara, Kalpesh, et al.
Publicado: (2020)

Broadening perspectives of global health – Prospects for AYUSH and integrative medicine
por: Payyappalli, Unnikrishnan
Publicado: (2018)

Immunity against COVID-19: Potential role of Ayush Kwath
por: Gautam, Shankar, et al.
Publicado: (2022)

AYUSH Cancer Conclave 2019 Accepted Oral Papers with Abstracts
Publicado: (2019)

AYUSH Cancer Conclave 2019 Accepted Posters Papers with Abstracts
Publicado: (2019)

Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p05bfrv7qepmfg4oidd6m9m68o